Abstract
BLM is sumoylated in response to replication stress. We have studied the role of BLM sumoylation in physiologically normal and replication-stressed conditions by expressing in BLM-deficient cells a BLM with SUMO acceptor-site mutations, which we refer to as SUMO-mutant BLM cells. SUMO-mutant BLM cells exhibited multiple defects in both stressed and unstressed DNA replication conditions, including, in hydroxyurea-treated cells, reduced fork restart and increased fork collapse and, in untreated cells, slower fork velocity and increased fork instability as assayed by track-length asymmetry. We further showed by fluorescence recovery after photobleaching that SUMO-mutant BLM protein was less dynamic than normal BLM and comprised a higher immobile fraction at collapsed replication forks. BLM sumoylation has previously been linked to the recruitment of RAD51 to stressed forks in hydroxyurea-treated cells. An important unresolved question is whether the failure to efficiently recruit RAD51 is the explanation for replication stress in untreated SUMO-mutant BLM cells.
Introduction
DNA replication is a highly coordinated process involving many protein factors. Some factors are stably associated with the replication fork, carrying out functions related to chromosome duplication, whilst other factors associate with the fork when replication is perturbed by DNA damaging agents or inhibitors of polymerases (Dungrawala et al., 2015). Some factors are known to function in both unperturbed and perturbed DNA replication, raising the question whether these factors are responding to damage encountered from physiological levels of DNA lesions generated by normal cellular processes, such as reactive oxygen species, or other sorts of replication limitations that are present in normal, unchallenged cells, such as “difficult-to-replicate DNA,” or perhaps responding to both conditions (Zeman and Cimprich, 2014). The determinants of difficult-to-replicate DNA are not fully understood, but certain types of repeat DNA such as the G-quadruplex-forming DNAs at telomeres provide a potent example. The BLM helicase is one of those factors known to associate with replication forks during unperturbed and perturbed DNA replication (Cunniff et al., 2017), and it represents a tool to better understand the characteristics of difficult-to-replicate DNA.
The BLM gene was identified as mutated in persons affected by the autosomal recessive, clinical entity Bloom syndrome (Ellis et al., 1995). Cells from persons with Bloom syndrome exhibit a striking genomic instability that is characterized by elevated levels of homologous recombination, as evidenced by tenfold higher levels of sister-chromatid exchange and up to fifty times higher levels of quadriradial figures, thought to be the cytogenetic manifestation of mitotic recombination between homologous chromosomes, in appropriately prepared metaphase chromosomes from untreated cells (German et al., 1965; Chaganti et al., 1974). The higher levels of homologous recombination are associated with increased loss of heterozygosity in persons with Bloom syndrome (Groden et al., 1990), which has been associated with increased carcinogenesis, as demonstrated in a hypomorphic Blm mouse model (Luo et al., 2000). These correlated factors are likely to be a major contributor to the extraordinary cancer predisposition of persons with Bloom syndrome (German, 1997; Flanagan and Cunniff, 2006).
As an ATP-dependent DNA helicase, BLM prefers substrates resembling replication and recombination intermediates (Bythell-Douglas and Deans, 2020). BLM is complexed with Topoisomerase III alpha, RMI1, and RMI2 (Meetei et al., 2003), and this complex has the unusual capacity to disentangle double Holliday junctions by dissolution (Wu and Hickson, 2003; Raynard et al., 2006; Wu et al., 2006), which led to the interesting proposal that the high sister-chromatid exchange phenotype of Bloom syndrome cells could be accounted for by a default mechanism for double-Holliday-junction resolution that involved breakage and rejoining in the absence of the BLM complex. However, the disentangling activity of the BLM complex can unwind late-replication intermediates (Chan and West, 2018). Moreover, it is also plausible that BLM has a function in synthesis-dependent single strand annealing (Adams et al., 2003), which is the predominant repair pathway for the repair of DNA double strand breaks (DSB) in fruit flies, by directing recombination-associated replication intermediates away from the double Holliday junction pathway.
There is evidence that BLM has a role supporting DNA replication, even though BLM-deficient cells are viable. Indirect immunofluorescence analysis has associated BLM with DNA synthesis in a late-replicating subset of replication forks by co-localization with PCNA and pulse-labelled bromodeoxyuridine (Yankiwski et al., 2000; Zhang et al., 2005). Bloom syndrome cells exhibit defects in Okazaki fragment maturation, as assayed by gel electrophoresis (Lonn et al., 1990), possibly by stimulating flap endonuclease FEN1 activity and prevention of intermediates that stimulate illegitimate homologous recombination (Sharma et al., 2004; Bartos et al., 2006). BLM interacts with the MCM6 subunit of the replicative helicase, and disruption of this interaction leads to supranormal replication fork velocities (Shastri et al., 2021). Replication track analysis of single DNA molecules comparing untreated Bloom syndrome cells to normal cells has shown slower replication fork velocity, increased fork collapse, and increased compensatory dormant origin firing (Davies et al., 2007; Rao et al., 2007). BLM associates with telomere DNA and ribosomal DNA during DNA synthesis, and in BLM-deficient cells, DNA damage accumulates at these genomic locations (Killen et al., 2009; Sfeir et al., 2009; Zimmermann et al., 2014; Drosopoulos et al., 2015), suggesting that BLM has roles at specific, difficult-to-replicate DNA sequences. In Drosophila melanogaster, BLM has a critical role in replication of repetitive DNA sequences during the rapid nuclear synthesis phase of the syncytial blastoderm (Ruchert et al., 2022). Finally, analysis of Xenopus laevis BLM in the frog oocyte replication system showed that, in the absence of drug-induced replication-associated DNA damage, X. laevis BLM associated with replicating chromatin after origin unwinding had occurred, and immuno-depletion of BLM led to the accumulation of DSBs (Li et al., 2004). Accumulation of DSBs in BLM-deficient cells could result from replication defects that lead directly to breakage, or they could be a consequence of under-replication, because BLM has a function in late metaphase disentangling under-replicated segments between sister chromatids (visualized as so-called ultra-fine DNA bridges or UFBs; Chan et al., 2009). Under-replicated segments not resolved by the BLM complex can be resolved instead by breakage and break-induced replication either in metaphase or DSB repair in the next cell cycle in the daughter cell (Minocherhomji et al., 2015; Bhowmick et al., 2016; Spies et al., 2019).
Hydroxyurea (HU) is an inhibitor of ribonucleotide reductase that stalls replication forks by reducing by approximately 50% the levels of dATP and dGTP (Vesela et al., 2017). BLM along with ssDNA binding protein RPA and the recombinase RAD51 are recruited to stalled replication forks immediately after exposure to HU and these proteins accumulate there over time in HU (Dungrawala et al., 2015). The time-dependent accumulation is thought to be due to nascent-strand resection at the fork (Schlacher et al., 2011); however, resection of one-ended DNA breaks could also comprise a part of the total loss of nascent strand DNA. If cells are left in HU for more than 12 h, then stalled forks can collapse, which is defined by replication track analysis as stalled forks that are unable to restart. Accordingly, treatment of cells with HU for 2–5 h or 16 h is an experimental approach to compare responses to replication stress that result in fork stalling or collapse, respectively. It is worthy of note that the propensity of forks to collapse with prolonged HU treatment is species- and cell type-dependent (Hanada et al., 2007; Petermann et al., 2010).
Many proteins associated with the replication fork and active in replication-associated homologous recombination are SUMO substrates (Xiao et al., 2015). We previously found that BLM was sumoylated, predominantly by SUMO2, with preferred SUMO acceptor sites at lysine 317 and lysine 331 (Eladad et al., 2005; Zhu et al., 2008). To address the role of sumoylation in regulation of BLM function, we introduced lysine-to-arginine mutations at amino acids 317 and 331 in a GFP-BLM expression construct and tested for complementation of cellular phenotypes of Bloom syndrome cells. The mutant BLM induced an increase of γ-H2AX foci and diffuse nuclear γ-H2AX in untreated cells, suggesting a mild and chronic defect in DNA replication. Importantly, although spontaneous sister chromatid exchange levels were complemented to normal, RAD51 did not localize with γ-H2AX at sites of replication stress, and we found that RAD51 bound avidly to sumoylated BLM in vitro, suggesting sumoylation of BLM is required for efficient recruitment and retention of RAD51 to collapsed replication forks mediated by a SUMO interaction motif (Ouyang et al., 2009; Bergink et al., 2013; Ouyang et al., 2013; Shima et al., 2013). Because RAD51 has a role in maintaining replication fork stability and response to replication damage (Zellweger et al., 2015; Mijic et al., 2017), we hypothesized that replication dynamics, including fork velocity, fork stalling and stability, and fork collapse would be substantially altered in SM-BLM cells. In the present brief report, we examined replication dynamics by replication track analysis and found multiple defects in unperturbed DNA replication and in HU-treated cells that expressed the SUMO-mutant BLM. These results demonstrated that BLM sumoylation is required for normal replication in unperturbed DNA synthesis.
Material and Methods
Cell Lines
As described previously (Ouyang et al., 2009), we introduced into the Bloom syndrome cell line GM08505, which is an SV40-transformed fibroblast cell line that has no detectable BLM by Western blot analysis, GFP-BLM expression constructs that encoded either a normal BLM or a BLM with K317R and K331R mutations. We will hereafter refer to cells that expressed the GFP-BLM construct as BLM+ cells and cells expressing the GFP-BLM K317R/K331R construct as SM-BLM cells, for SUMO-mutant BLM-expressing cells. BLM+ cells are fully complemented for all the cellular phenotypes of Bloom syndrome cells that we have scored so far, including the high sister chromatid exchange phenotype. Cells were cultivated as previously described (Eladad et al., 2005).
Microfluidic-Assisted Replication Track Analysis
Microfluidic-assisted replication track analysis (maRTA) was performed as previously described (Sidorova et al., 2009; Pond et al., 2019). Briefly, DNA was prepared in agarose plugs, DNA stretching was performed on 3-aminopropyltriethoxysilane coated slides (LabScientific) with polydimethylsiloxane (PDMS) capillary microchannel molds, and immunodetection and image acquisition of iododeoxyuridine- (IdU), chlorodeoxyuridine- (CldU), and ssDNA-labeled DNA molecules were performed as previously described (Pond et al., 2019). Only replication signals located on intact DNA fibers were selected for analysis. The maRTA experiments were performed twice on each cell line.
For assessment of fork restart, cells were pulse-labelled with 100 µM IdU for 40 min. Cells were then treated or not with 2 mM HU for 5 h and subsequently released into fresh medium containing 100 μM CldU for 40 min. Signals corresponding to fork restart (dual labelling), fork collapse and termination (IdU label only), and new origin firing (CldU label only) were scored and expressed as a percentage of total signals. For measurement of fork velocity, fork density, and IdU/CldU ratio, cells were sequentially pulse-labelled with 100 μM of IdU and CldU for 40 min.
IdU/CldU ratio were calculated as the ratio of the longest track over the shortest, thus all ratios are ≥ 1 (Techer et al., 2013). Fork density/Mb was calculated by dividing the number of active replication forks by the total length of DNA fibers analyzed, normalized to the fraction of cells in S phase, assessed by flow cytometry (Bialic et al., 2015). Over 300 Mb of total DNA length was measured per condition, and these measures were normalized to percentage of cells in S phase. Signals were measured using NIH Image J software and the data analyzed in GraphPad Prism. Statistical analyses were performed in GraphPad Prism. A Mann-Whitney test was performed to determine statistical significance for fork velocity and IdU/CldU ratio; a Two-Way ANOVA test was performed to test stalled fork restart and collapse, and Ordinary One-Way ANOVA was performed to test variation in fork density.
Fluorescence Recovery After Photobleaching (FRAP)
BLM+ or SM-BLM cells were treated with 2 mM HU for 24 h and imaged using Leica SP5-II confocal microscope using a 40x/1.25NA PL Apo (oil) lens. Single-foci regions of interest (ROIs) were photobleached using a VIS Ar-488 laser. Recovery was obtained for 1 minute following bleaching at 0.5 s intervals. Time to half of maximum recovery was calculated and represented as T1/2. Error bars represent SEM across three independent experiments.
Western Blot Analysis
Cells were lysed in RIPA buffer supplemented with 5 mM EDTA, 1 mM EGTA, 25 mM sodium fluoride, 1 mM sodium orthovanadate, 1 mM phenylmethane sulfonyl fluoride (PMSF) with 1x EDTA-free protease inhibitor (GoldBio ProBlock Gold; GB-108–2). Protein concentration were measured using Pierce 660 nm Protein Assay. 15 μg of total protein from cell lysates were separated by electrophoresis through Bio-Rad 4%–15% acrylamide mini-PROTEAN TGX gels or Bio-Rad Criterion 10% acrylamide TGX gels, and transferred onto Amersham™ Protran™ 0.45 μm nitrocellulose membranes by semi-dry transfer. To control for protein loading and transfer, prior to blocking, the membranes were stained with Ponceau S (Sigma P7170) for 5–10 min, washed two times with 1% glacial acetic acid in water, and imaged. Membranes were blocked for 1 h in either Tris-buffered saline (TBS) with 5% Bio-Rad Blotting-Grade Blocker, or Prometheus OneBlock Western-CL Blocking Buffer, then incubated with primary antibody in 5% BSA in TBS + 0.1% Tween-20 overnight at 4°C. After washing with TBS-T the membranes were incubated with secondary antibodies (HRP-linked anti-mouse, Cell Signaling Technology 7076 or HRP-linked anti-rabbit, GE Healthcare NA934 V); imaging was done on a Syngene G: Box Chemi gel documentation system. Primary antibodies for immunodetection were obtained as follows: anti-BLM (Beresten et al., 1999), anti-CHK1 (Cell Signaling Technology; 2345), anti-phospho-CHK1 (Ser345) (Cell Signaling Technology; 2348), anti-RPA2 (Abcam; ab2175), anti-phospho-RPA2 (Ser4/8) (Bethyl; A300-245 A), and γ-H2AX (Cell Signaling Technology; 9718).
Results
SUMO-Mutant BLM Failed to Restart Some Stalled Replication Forks
BLM sumoylation is required for repair of collapsed forks (Ouyang et al., 2009) and for licensing of HR repair factors upon fork stalling (Ouyang et al., 2013), suggesting that BLM sumoylation promotes fork stabilization upon replication stress. Using maRTA, we assessed the ability of stalled forks to restart after replication stress. After 5 h of HU treatment, in BLM+ cells, most of the stalled replication forks were able to restart (Figures 1A,B), as previously described for those conditions (Petermann et al., 2010). Consistent with previous reports (Davies et al., 2007), BLM-deficient cells showed a reduced frequency in fork restart, which was associated with increased fork collapse (Figures 1A–C). Similarly, SM-BLM cells showed a defect in fork restart. Increased fork collapse was associated with increased new origin firing; however, this effect was smaller in SM-BLM cells compared to BLM-deficient cells and did not reach statistical significance, most likely due to the low number of events observed (Figures 1A,D). Together, these results confirmed that BLM sumoylation was required for efficient fork restart upon replication stress.
FIGURE 1
SUMO-Mutant BLM Showed Impaired Replication Fork Progression
BLM plays a role in unperturbed DNA replication and BLM-deficient cells exhibit slower fork progression (Rao et al., 2007). In addition, constitutive DNA damage was present in SM-BLM cells, as measured by γ-H2AX foci and RPA foci (Ouyang et al., 2009; Ouyang et al., 2013), which suggested these cells experience chronic perturbations in DNA replication in the absence of exogenously induced DNA damage. Consequently, we measured replication fork progression under unperturbed conditions using maRTA. SM-BLM cells exhibited a median fork velocity of 0.70 kb/min compared to 1.18 kb/min in BLM+ cells (Figure 2A). As previously described, BLM-deficient GM08505 cells also exhibited reduction of fork progression, with a median of 1.01 kb/min (Figure 2A). Together, these results indicated that BLM sumoylation was required for normal DNA synthesis in physiologically normal conditions.
FIGURE 2
To determine if this slower fork progression was associated with increased firing of replication origins, global fork density was analyzed (Table 1). We found that fork density was increased in BLM-deficient GM08505 cells (2.0 forks/Mb), similar to what was found in previous reports (Davies et al., 2007; Rao et al., 2007). Fork density in SM-BLM cells (1.9 fork/Mb) was also higher compared to BLM+ cells (1.2 fork/Mb). The higher fork density found in SM-BLM cells indicated that SM-BLM cells fire more origins of replication than BLM+ cells.
TABLE 1
| BLM+ | SM-BLM | BLM- | ||
|---|---|---|---|---|
| Experiment 1 | Normalized total DNA (Mb)a | 126.21 | 114.26 | 127.80 |
| Total forks | 162 | 207 | 263 | |
| No. forks/Mb | 1.3 | 1.8 | 2.1 | |
| Experiment 2 | Normalized total DNA (Mb)a | 262.29 | 133.36 | 156.72 |
| Total forks | 276 | 271 | 292 | |
| No. forks/Mb | 1.1 | 2.0 | 1.9 | |
| AVERAGE | No. forks/Mb | 1.2 | 1.9* | 2.0* |
DNA replication fork density (forks/Mb DNA).
BLM+, cells that express a normal GFP-BLM protein; SM-BLM, cells that express a SUMO-mutant GFP-BLM protein; BLM-, the parental GM08505 SV40-transformed fibroblast cell line derived from a person with Bloom syndrome. No. fork/Mb is a measure of fork density.
Over 300 Mb of DNA was measured for each condition and then normalized to the fraction of cells in S phase.
*p < 0.05 by Ordinary One Way ANOVA, comparing SM-BLM or BLM- to BLM+.
Shorter replication tracks could reflect increased fork stalling. To assess fork stalling, we measured IdU/CldU ratio of active replication forks (Figures 2B–E). If replication machinery is continuously progressing, the length of IdU and CldU tracks should be similar (ratio ∼ 1). However, if replication machinery is encountering obstacles during one of the pulses, this ratio will deviate from one. IdU/CldU ratio in SM-BLM cells indicated an increase of fork stalling (Figure 2B). Nearly 40% of forks (39.7%) exhibited an asymmetry between the two tracks (Figure 2D) compared to 25.7% for BLM+ cells (Figure 2C). Interestingly, based on this parameter, BLM-deficient GM08505 cells exhibited similar levels of fork stalling compared to BLM+ cells (Figures 2B,E), which was inconsistent with previous results reporting increased fork stalling in BLM-deficient cells as measured by sister-forks asymmetry (Rao et al., 2007). In summary, the slower velocity of replication forks and the increased IdU/CldU ratio in SM-BLM cells compared to BLM-deficient cells were consistent with a more severe DNA replication defect in SM-BLM cells.
Slower SUMO-Mutant BLM Turnover at Stalled Replication Forks
Sumoylation is a dynamic process, allowing protein-protein interaction, modulating protein function, and promoting protein turn-over (Hay, 2005). Study of the yeast homolog Sgs1, suggested that BLM is most likely recruited to and retained at stalled forks through its SUMO interaction motif by interaction with a sumoylated form of the SMC5/6 complex (Eladad et al., 2005; Bonner et al., 2016). Once recruited to the SMC5/6 complex, BLM is sumoylated by the NSMCE2 SUMO E3 ligase component of that complex (Pond et al., 2019). We have shown previously that SUMO-BLM is a substrate for SUMO-targeted ubiquitin ligase (STUbL) RNF4, suggesting that sumoylation may be required for BLM turnover at stalled and collapsed forks (Ellis et al., 2021). Consequently, we asked whether BLM dynamics at collapsed replication forks were affected by sumoylation, by performing fluorescence recovery after photobleaching (FRAP) at sites of replication collapse in BLM+ and SM-BLM cells generated by treatment with 2 mM HU for 24 h (Figure 3). Following photobleaching of GFP-BLM foci, signal recovery of SM-BLM was significantly slower compared to recovery in BLM+ cells (Figure 3). In addition, the immobile fraction of SUMO-mutant BLM is increased to 41.60%, compared to 34.40% for normal BLM. These results indicated that SM-BLM is less mobile at sites of replication stress in the absence of sumoylation. We concluded that sumoylation facilitates normal BLM turnover at stalled and collapsed replication forks.
FIGURE 3
ATR Not Activated by SM-BLM in Unperturbed Cells
ATR is activated during replication stress, and it regulates the firing of dormant origins and the exposure of ssDNA in response to HU treatment. We sought evidence for increased replication stress in unperturbed SM-BLM cells by analysis of CHK1 phosphorylation by Western blot. Concomitantly, we measured the extent of fork damage in HU-treated cells in the presence and absence of ATR inhibitor by measuring RPA hyper-phosphorylation at serine 4 and 8 and γ-H2AX. No increase in CHK1 phosphorylation was evident in SM-BLM cells in the absence of HU treatment, suggesting that the extent or nature of replication stress under physiologic conditions in these cells does not result in ATR activation (Figure 4). In contrast, as we have reported previously (Ouyang et al., 2009; Ouyang et al., 2013), HU induced excess levels of RPA phosphorylation and γ-H2AX in SM-BLM cells compared to BLM+ cells, and inhibition of ATR exacerbated these effects more in SM-BLM cells, suggesting that SUMO-mutant BLM and ATR effectively acted additively at stressed replication forks.
FIGURE 4
DISCUSSION
Protein sumoylation is a highly dynamic process in which, under the appropriate conditions, a large fraction of the pool of a protein can be sumoylated, but the steady-state levels of sumoylated protein may exhibit a very limited change. Sumoylated proteins can be difficult to detect because desumoylation activities of SUMO proteases (SENPs) and SUMO-mediated protein degradation through the ubiquitylation activity of RNF4 keep the steady-state levels of sumoylated protein low. Based on Western blot analysis of cell lysates and immunoprecipitated BLM, under uninduced conditions the steady-state levels of sumoylated BLM are less than 2% of total BLM protein (Eladad et al., 2005; Zhu et al., 2008), but with HU treatment they can increase several fold yet still be difficult to detect. Nevertheless, cells that express SM-BLM protein exhibit striking defects in replication fork velocity, IdU/CldU ratios, and the frequencies of HU-induced collapsed forks that are at least as severe or more severe than what is seen in BLM-deficient GM08505 cells. In fact, the unique phenotypic effects associated with expression of a SUMO-mutant form of BLM—including the increased levels of focal and diffuse γ-H2AX, the high levels of RPA foci in untreated and HU-treated cells, and the failure to properly recruit and retain RAD51 to collapsed forks—very likely trace their origin to defects in normal progression of the replication fork. Sumoylation was shown here to be an essential part of BLM’s function at DNA replication forks in both unperturbed and perturbed DNA synthesis. Although sumoylation has been previously implicated in normal DNA replication in studies of induced replication stress, to our knowledge, the present results are the first demonstration of a strong dependence on a specific sumoylation event for unperturbed, physiologically normal DNA synthesis.
Our data suggested fork stalling is more severe in SM-BLM cells compared to BLM-deficient cells based on the γ-H2AX, RPA, and RAD51 phenotypes and based on our measure of fork instability using the IdU/CldU ratio. However, Rao et al. (2007) measured fork instability using fork asymmetry, that is, testing symmetry between two forks emanating from a single origin. We did not see a difference in IdU/CldU ratio in GM08505 cells, but Rao et al. observed sister-fork asymmetry in the same cell line. Perhaps the IdU/CldU ratio test is a less sensitive test for a fork-stalling defect than sister-fork asymmetry. Alternatively, IdU/CldU ratio could be more sensitive to the greater fork velocity difference in SM-BLM cells compared to BLM-deficient cells.
In genetic terms, the SUMO lysine to arginine substitutions of BLM at amino acids 317 and 331 are separation-of-function mutations. Sumoylation appears to strongly influence BLM’s associations with two central factors in homologous recombination by diminishing its interaction with RAD51 and increasing its interaction with RPA, without affecting its DNA helicase activity yet increasing its affinity for ssDNA (Ouyang et al., 2009; Ouyang et al., 2013). BLM is known to interact with DNA2 to catalyze resection of 5′ recessed ends of DSBs (Gravel et al., 2008; Nimonkar et al., 2011; Soniat et al., 2019; Whelan and Rothenberg, 2021), and the increased levels of focal RPA after prolonged HU treatment indicates that SM-BLM promotes resection, that is, it is hypermorphic with respect to the fork resection phenotype. A separation-of-function mutation that interrupts BLM’s interaction with RPA has no effect on DSB end resection or on BLM’s and RPA’s association with UFBs; moreover, it complements the high sister-chromatid exchange phenotype (Shorrocks et al., 2021). However, the RPA interaction-negative BLM is associated with increased replication stress, as evidenced by slower fork velocity and lower IdU/CldU ratio, and it exhibits less fork resection, as evidenced by less RPA accumulation at collapsed forks in HU-treated cells. We suggest that the function of BLM sumoylation is to tip the balance away from fork resection and in favor of a more stable interaction with RAD51, which has the salutary effect of fork stabilization at difficult-to-replicate DNAs. The work of Shorrocks and colleagues further suggests that interaction with RPA is also salutary but not in excess as seen with the SM-BLM mutant.
The most striking of the replication defects in SM-BLM cells related to the reduction in fork velocity, which exhibited a more severe phenotype compared to BLM-deficient cells. The FRAP results showed that SUMO-mutant BLM is less mobile at stalled forks, suggesting that sumoylation regulates protein turnover there and possibly relieves some inhibitory activity of the BLM complex. It may also destabilize interactions with protein factors besides RPA. Recently, it was shown that BLM interacts with MCM6 and disruption of BLM interaction with MCM6 results in increased fork velocity in unperturbed cells (Shastri et al., 2021). These results raise the possibility that BLM sumoylation negatively regulates interaction with MCM6, thereby modulating fork velocity in response to replication stress or at sites of difficult-to-replicate DNA.
With regards to the mechanism by which BLM sumoylation facilitates the function of the replisome in unperturbed, physiological normal DNA synthesis, we suggest the following model. There is evidence in yeast that SMC5/6 complex is a sensor of fork slowing or pausing (Menolfi et al., 2015; Peng et al., 2018). SMC5/6 is recruited to forks that encounter difficult-to-replicate DNA, which is formally defined as regions of DNA in which the replisome slows or pauses. Binding of SMC5/6 to the replisome activates the E3 SUMO ligase of the NSMCE2 component of the SMC5/6 complex. The SMC5/6 complex becomes sumoylated, BLM is recruited to the replisome from the PML nuclear bodies, and NSMCE2 sumoylates BLM. Earlier work showed that RAD51 is not recruited to collapsed replication forks in SM-BLM cells (Ouyang et al., 2009) and RAD51 is required to stabilize stalled forks (Zellweger et al., 2015; Mijic et al., 2017). Thus, replication forks that encounter DNA damage or difficult-to-replicate DNA in which the replisome slows or pauses require BLM sumoylation for recruitment of RAD51 and stabilization of the fork. Consequently, in SM-BLM cells, unperturbed replication forks have a propensity to collapse, which induces ATR-dependent dormant origin firing. In BLM-deficient cells, RAD51 gets recruited to stressed forks, suggesting further that the presence of the SUMO-mutant BLM at stressed forks blocks the recruitment of RAD51, whereas in BLM-deficient cells RAD51 can be recruited directly to stressed forks through RAD51’s sumo-interaction motif binding to sumoylated SMC5/6 complex. Future tests of this model in mammalian cells would include complementation of SM-BLM cell defects by independent recruitment of RAD51 to stressed replication forks, further analysis of the SUMO interaction motif on BLM and RAD51, and analysis of separation of function alleles of NSMCE2.
As noted above, SM-BLM was less mobile at stalled forks, suggesting that one role of sumoylation is to control the turnover of BLM during replication stress. Consequently, we might expect that inhibition of the processing of SUMO-BLM by the STUbL RNF4 by siRNA depletion might produce some similar phenotypes by leaving an excess of immobile, albeit sumoylated, BLM protein at sites of damage. We recently reported that SUMO-BLM is a substrate of RNF4 and RNF4 depletion led to a hyper-accumulation of SUMO-BLM at collapsed forks generated by prolonged HU treatment (Ellis et al., 2021). Consequently, we expected that sumoylated BLM would also be less mobile at collapsed forks. To some surprise, we tested GFP-BLM mobility in HU-treated RNF4-depleted cells and did not see a reduction in its mobility (data not shown). Because this is a negative result, we are careful not to over-interpret it. Our previous analysis of the effects of RNF4 depletion were conducted mainly in U2OS cells, and we do not know how much SUMO-BLM accumulates in the SV40-transformed fibroblast cells used in the present experiments upon depletion of RNF4 by siRNA transfection. In support of this concern, the alterations in replication dynamics, namely, the high levels of new origin firing, that we observed in RNF4-depleted U2OS cells were not observed when replication track analysis was carried out in RNF4-depleted BLM+ cells. Further analysis of SUMO-BLM levels in RNF4-depleted cells needs to be carried out, and, for this analysis to proceed, cells expressing a His-tagged SUMO2 must be generated to facilitate detection of low levels of SUMO-BLM.
In a careful examination of other phenotypes, we noted little phenotypic concordance between SM-BLM cells and RNF4-deficient cells. The differences are enumerated as follows (Ouyang et al., 2009; Ouyang et al., 2013; Ellis et al., 2021): 1) Numbers of BLM foci in untreated SM-BLM cells were 2.5 times higher but these numbers were not increased after treatment with HU, whereas BLM foci in untreated RNF4-deficient cells were no different from untreated control and HU treatment increased the median number by over 20%. 2) γ-H2AX focal numbers were significantly elevated in untreated SM-BLM cells, and they increased excessively after HU treatment, but the numbers of γ-H2AX foci were not different from control in untreated or HU-treated RNF4-deficient cells. 3) Focal concentrations of RPA were excessively elevated in untreated and HU-treated SM-BLM cells, but the numbers of RPA foci in RNF4-deficient cells were the same as in normal cells. But, in RNF4-deficient cells, there was instead an increase in the size of RPA foci. 4) There were nearly half as many RAD51 foci in HU-treated SM-BLM whereas the reduction in RAD51 foci in RNF4-deficient cells was not significant. Thus, the immunofluorescent phenotypes for BLM, RPA, RAD51, and γ-H2AX seen in RNF4-deficient cells were not at all similar to the phenotypes observed in SM-BLM cells. 5) DSBs were elevated in SM-BLM cells and not different from normal in RNF4-deficient cells. Finally, 6) the replication dynamics, including fork velocity, fork restart, and fork collapse were not significantly different from control in RNF4-deficient cells treated with HU for 2 hours; instead, a difference was only seen after prolonged HU treatment, and the most notable finding there was an excess of new origin firing relative to collapsed forks. Altogether, the phenotypes of RNF4-deficient cells are different from those of SM-BLM cells, suggesting that there is a meaningful difference between the molecular pathology of SUMO-mutant BLM and a hyper-accumulation of sumoylated BLM. Because multiple homologous recombination proteins are sumoylated in response to replication stress (Xiao et al., 2015), RNF4 depletion might be expected to affect the turnover of multiple factors at stalled forks. Consequently, the phenotypic differences between SM-BLM and RNF4 depletion might also be traced to SUMO-specific modification events of other repair factors.
Cancer cells are often sensitive to the induction of replication stress. The manifestations described here of replication stress under physiologically normal conditions in cells that express a SUMO-mutant BLM suggest that inhibition of BLM sumoylation could make a useful target for chemotherapeutic development. The technical challenge of achieving specific anti-sumoylation activity with a small molecule might be approached through inhibiting BLM’s interaction with the SUMO E3 ligase NSMCE2. More broadly, the genomic and chromatin-associated characteristics of difficult-to-replicate DNA and of the role of sumoylation and other responders to replication stress in facilitating replication fork translocation across these regions are of fundamental importance to our understanding of the process of faithful chromosome duplication.
Statements
Data availability statement
The original contributions presented in this study are included in the article and supplementary tables. Further inquiries can be directed to the corresponding author
Author contributions
CR, NE, KP conceptualized and designed the study; CR, KP, and MY carried out experiments; NE secured the environment; CR and NE drafted the manuscript. All authors revised the manuscript, and they read and approved the submitted version.
Funding
This work was supported by a grant from the National Institute of Health R01CA140804 (NAE) and the National Cancer Institute Cancer Center Support Grant P30CA023074.
Acknowledgments
We thank Stefan Myhajlenko and Kevin Nordquist from Arizona State University NanoFab for the fabrication of the SU-8-negative master for the casting of PDMS microchannels. We also thank the University of Arizona Microscopy Alliance for their help with imaging for maRTA and FRAP. Government sponsors take no responsibility for the content of this article.
Conflict of interest
CdR is currently an employee and shareholder of AstraZeneca.
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmolb.2022.875102/full#supplementary-material
References
1
AdamsM. D.McVeyM.SekelskyJ. J. (2003). Drosophila BLM in Double-Strand Break Repair by Synthesis-dependent Strand Annealing. Science299, 265–267. 10.1126/science.1077198PubMed Abstract | CrossRef Full Text | Google Scholar
2
BartosJ. D.WangW.PikeJ. E.BambaraR. A. (2006). Mechanisms by Which Bloom Protein Can Disrupt Recombination Intermediates of Okazaki Fragment Maturation. J. Biol. Chem.281, 32227–32239. 10.1074/jbc.m606310200PubMed Abstract | CrossRef Full Text | Google Scholar
3
BerestenS. F.StanR.van BrabantA. J.YeT.NaureckieneS.EllisN. A. (1999). Purification of Overexpressed Hexahistidine-Tagged BLM N431 as Oligomeric Complexes. Protein Expr. Purif.17, 239–248. 10.1006/prep.1999.1135PubMed Abstract | CrossRef Full Text | Google Scholar
4
BerginkS.AmmonT.KernM.SchermellehL.LeonhardtH.JentschS. (2013). Role of Cdc48/p97 as a SUMO-Targeted Segregase Curbing Rad51-Rad52 Interaction. Nat. Cell Biol.15, 526–532. 10.1038/ncb2729PubMed Abstract | CrossRef Full Text | Google Scholar
5
BhowmickR.MinocherhomjiS.HicksonI. D. (2016). RAD52 Facilitates Mitotic DNA Synthesis Following Replication Stress. Mol. Cell64, 1117–1126. 10.1016/j.molcel.2016.10.037PubMed Abstract | CrossRef Full Text | Google Scholar
6
BialicM.CoulonV.DracM.GostanT.SchwobE. (2015). Analyzing the Dynamics of DNA Replication in Mammalian Cells Using DNA Combing. Methods Mol. Biol.1300, 67–78. 10.1007/978-1-4939-2596-4_4PubMed Abstract | CrossRef Full Text | Google Scholar
7
BonnerJ. N.ChoiK.XueX.TorresN. P.SzakalB.WeiL.et al (2016). Smc5/6 Mediated Sumoylation of the Sgs1-Top3-Rmi1 Complex Promotes Removal of Recombination Intermediates. Cell Rep.16, 368–378. 10.1016/j.celrep.2016.06.015PubMed Abstract | CrossRef Full Text | Google Scholar
8
Bythell-DouglasR.DeansA. J. (2021). A Structural Guide to the Bloom Syndrome Complex. Structure29, 99–113. 10.1016/j.str.2020.11.020PubMed Abstract | CrossRef Full Text | Google Scholar
9
ChagantiR. S. K.SchonbergS.GermanJ. (1974). A Manyfold Increase in Sister Chromatid Exchanges in Bloom's Syndrome Lymphocytes. Proc. Natl. Acad. Sci. U. S. A.71, 4508–4512. 10.1073/pnas.71.11.4508PubMed Abstract | CrossRef Full Text | Google Scholar
10
ChanK. L.Palmai-PallagT.YingS.HicksonI. D. (2009). Replication Stress Induces Sister-Chromatid Bridging at Fragile Site Loci in Mitosis. Nat. Cell Biol.11, 753–760. 10.1038/ncb1882PubMed Abstract | CrossRef Full Text | Google Scholar
11
ChanY. W.WestS. C. (2018). A New Class of Ultrafine Anaphase Bridges Generated by Homologous Recombination. Cell Cycle17, 2101–2109. 10.1080/15384101.2018.1515555PubMed Abstract | CrossRef Full Text | Google Scholar
12
CunniffC.BassettiJ. A.EllisN. A. (2017). Bloom's Syndrome: Clinical Spectrum, Molecular Pathogenesis, and Cancer Predisposition. Mol. Syndromol.8, 4–23. 10.1159/000452082PubMed Abstract | CrossRef Full Text | Google Scholar
13
DaviesS. L.NorthP. S.HicksonI. D. (2007). Role for BLM in Replication-Fork Restart and Suppression of Origin Firing after Replicative Stress. Nat. Struct. Mol. Biol.14, 677–679. 10.1038/nsmb1267PubMed Abstract | CrossRef Full Text | Google Scholar
14
DrosopoulosW. C.KosiyatrakulS. T.SchildkrautC. L. (2015). BLM Helicase Facilitates Telomere Replication during Leading Strand Synthesis of Telomeres. J. Cell Biol.210, 191–208. 10.1083/jcb.201410061PubMed Abstract | CrossRef Full Text | Google Scholar
15
DungrawalaH.RoseK. L.BhatK. P.MohniK. N.GlickG. G.CouchF. B.et al (2015). The Replication Checkpoint Prevents Two Types of Fork Collapse without Regulating Replisome Stability. Mol. Cell59, 998–1010. 10.1016/j.molcel.2015.07.030PubMed Abstract | CrossRef Full Text | Google Scholar
16
EladadS.YeT.-Z.HuP.LevershaM.BerestenS.MatunisM. J.et al (2005). Intra-nuclear Trafficking of the BLM Helicase to DNA Damage-Induced Foci Is Regulated by SUMO Modification. Hum. Mol. Genet.14, 1351–1365. 10.1093/hmg/ddi145PubMed Abstract | CrossRef Full Text | Google Scholar
17
EllisN. A.GrodenJ.YeT.-Z.StraughenJ.LennonD. J.CiocciS.et al (1995). The Bloom's Syndrome Gene Product Is Homologous to RecQ Helicases. Cell83, 655–666. 10.1016/0092-8674(95)90105-1PubMed Abstract | CrossRef Full Text | Google Scholar
18
EllisN.ZhuJ.YagleM. K.YangW.-C.HuangJ.KwakoA.et al (2021). RNF4 Regulates the BLM Helicase in Recovery from Replication Fork Collapse. Front. Genet.12, 753535. 10.3389/fgene.2021.753535PubMed Abstract | CrossRef Full Text | Google Scholar
19
FlanaganM.CunniffC. M. (2006). “Bloom Syndrome,” in GeneReviews® [Internet]. Editors AamM. P.ArdingerH. H.PagonR. A.WallaceS. E.BeanL. J. H.GrippK. W.et al (Seattle, WA: University of Washington), 1993–2022. Google Scholar
20
GermanJ.ArchibaldR.BloomD. (1965). Chromosomal Breakage in a Rare and Probably Genetically Determined Syndrome of Man. Science148, 506–507. 10.1126/science.148.3669.506PubMed Abstract | CrossRef Full Text | Google Scholar
21
GermanJ. (1997). Bloom's Syndrome. XX. The First 100 Cancers. Cancer Genet. Cytogenet.93, 100–106. 10.1016/s0165-4608(96)00336-6PubMed Abstract | CrossRef Full Text | Google Scholar
22
GravelS.ChapmanJ. R.MagillC.JacksonS. P. (2008). DNA Helicases Sgs1 and BLM Promote DNA Double-Strand Break Resection. Genes Dev.22, 2767–2772. 10.1101/gad.503108PubMed Abstract | CrossRef Full Text | Google Scholar
23
GrodenJ.NakamuraY.GermanJ. (1990). Molecular Evidence that Homologous Recombination Occurs in Proliferating Human Somatic Cells. Proc. Natl. Acad. Sci. U.S.A.87, 4315–4319. 10.1073/pnas.87.11.4315PubMed Abstract | CrossRef Full Text | Google Scholar
24
HanadaK.BudzowskaM.DaviesS. L.van DrunenE.OnizawaH.BeverlooH. B.et al (2007). The Structure-specific Endonuclease Mus81 Contributes to Replication Restart by Generating Double-Strand DNA Breaks. Nat. Struct. Mol. Biol.14, 1096–1104. 10.1038/nsmb1313PubMed Abstract | CrossRef Full Text | Google Scholar
25
HayR. T. (2005). Sumo. Mol. Cell18, 1–12. 10.1016/j.molcel.2005.03.012PubMed Abstract | CrossRef Full Text | Google Scholar
26
KillenM. W.StultsD. M.AdachiN.HanakahiL.PierceA. J. (2009). Loss of Bloom Syndrome Protein Destabilizes Human Gene Cluster Architecture. Hum. Mol. Genet.18, 3417–3428. 10.1093/hmg/ddp282PubMed Abstract | CrossRef Full Text | Google Scholar
27
LiW.KimS.-M.LeeJ.DunphyW. G. (2004). Absence of BLM Leads to Accumulation of Chromosomal DNA Breaks during Both Unperturbed and Disrupted S Phases. J. Cell Biol.165, 801–812. 10.1083/jcb.200402095PubMed Abstract | CrossRef Full Text | Google Scholar
28
LönnU.LönnS.NylenU.WinbladG.GermanJ. (1990). An Abnormal Profile of DNA Replication Intermediates in Bloom's Syndrome. Cancer Res.50, 3141–3145. PubMed Abstract | Google Scholar
29
LuoG.SantoroI. M.McDanielL. D.NishijimaI.MillsM.YoussoufianH.et al (2000). Cancer Predisposition Caused by Elevated Mitotic Recombination in Bloom Mice. Nat. Genet.26, 424–429. 10.1038/82548PubMed Abstract | CrossRef Full Text | Google Scholar
30
MeeteiA. R.SechiS.WallischM.YangD.YoungM. K.JoenjeH.et al (2003). A Multiprotein Nuclear Complex Connects Fanconi Anemia and Bloom Syndrome. Mol. Cell Biol.23, 3417–3426. 10.1128/mcb.23.10.3417-3426.2003PubMed Abstract | CrossRef Full Text | Google Scholar
31
MenolfiD.DelamarreA.LengronneA.PaseroP.BranzeiD. (2015). Essential Roles of the Smc5/6 Complex in Replication through Natural Pausing Sites and Endogenous DNA Damage Tolerance. Mol. Cell60, 835–846. 10.1016/j.molcel.2015.10.023PubMed Abstract | CrossRef Full Text | Google Scholar
32
MijicS.ZellwegerR.ChappidiN.BertiM.JacobsK.MutrejaK.et al (2017). Replication Fork Reversal Triggers Fork Degradation in BRCA2-Defective Cells. Nat. Commun.8, 859. 10.1038/s41467-017-01164-5PubMed Abstract | CrossRef Full Text | Google Scholar
33
MinocherhomjiS.YingS.BjerregaardV. A.BursomannoS.AleliunaiteA.WuW.et al (2015). Replication Stress Activates DNA Repair Synthesis in Mitosis. Nature528, 286–290. 10.1038/nature16139PubMed Abstract | CrossRef Full Text | Google Scholar
34
NimonkarA. V.GenschelJ.KinoshitaE.PolaczekP.CampbellJ. L.WymanC.et al (2011). BLM-DNA2-RPA-MRN and EXO1-BLM-RPA-MRN Constitute Two DNA End Resection Machineries for Human DNA Break Repair. Genes Dev.25, 350–362. 10.1101/gad.2003811PubMed Abstract | CrossRef Full Text | Google Scholar
35
OuyangK. J.WooL. L.ZhuJ.HuoD.MatunisM. J.EllisN. A. (2009). SUMO Modification Regulates BLM and RAD51 Interaction at Damaged Replication Forks. PLoS Biol.7, e1000252. 10.1371/journal.pbio.1000252PubMed Abstract | CrossRef Full Text | Google Scholar
36
OuyangK. J.YagleM. K.MatunisM. J.EllisN. A. (2013). BLM SUMOylation Regulates ssDNA Accumulation at Stalled Replication Forks. Front. Genet.4, 167. 10.3389/fgene.2013.00167PubMed Abstract | CrossRef Full Text | Google Scholar
37
PengX. P.LimS.LiS.MarjavaaraL.ChabesA.ZhaoX. (2018). Acute Smc5/6 Depletion Reveals its Primary Role in rDNA Replication by Restraining Recombination at Fork Pausing Sites. PLoS Genet.14, e1007129. 10.1371/journal.pgen.1007129PubMed Abstract | CrossRef Full Text | Google Scholar
38
PetermannE.OrtaM. L.IssaevaN.SchultzN.HelledayT. (2010). Hydroxyurea-stalled Replication Forks Become Progressively Inactivated and Require Two Different RAD51-Mediated Pathways for Restart and Repair. Mol. Cell37, 492–502. 10.1016/j.molcel.2010.01.021PubMed Abstract | CrossRef Full Text | Google Scholar
39
PondK. W.de RentyC.YagleM. K.EllisN. A. (2019). Rescue of Collapsed Replication Forks Is Dependent on NSMCE2 to Prevent Mitotic DNA Damage. PLoS Genet.15, e1007942. 10.1371/journal.pgen.1007942PubMed Abstract | CrossRef Full Text | Google Scholar
40
RaoV. A.ContiC.Guirouilh-BarbatJ.NakamuraA.MiaoZ.-H.DaviesS. L.et al (2007). Endogenous γ-H2AX-ATM-Chk2 Checkpoint Activation in Bloom's Syndrome Helicase-Deficient Cells Is Related to DNA Replication Arrested Forks. Mol. Cancer Res.5, 713–724. 10.1158/1541-7786.mcr-07-0028PubMed Abstract | CrossRef Full Text | Google Scholar
41
RaynardS.BussenW.SungP. (2006). A Double Holliday Junction Dissolvasome Comprising BLM, Topoisomerase IIIα, and BLAP75. J. Biol. Chem.281, 13861–13864. 10.1074/jbc.c600051200PubMed Abstract | CrossRef Full Text | Google Scholar
42
RuchertJ. M.BradyM. M.McMahanS.LaceyK. J.LattaL. C.SekelskyJ.et al (2022). Blm Helicase Facilitates Rapid Replication of Repetitive DNA Sequences in Early Drosophila Development. Genetics220, iyab169. 10.1093/genetics/iyab169PubMed Abstract | CrossRef Full Text | Google Scholar
43
SchlacherK.ChristN.SiaudN.EgashiraA.WuH.JasinM. (2011). Double-strand Break Repair-independent Role for BRCA2 in Blocking Stalled Replication Fork Degradation by MRE11. Cell145, 529–542. 10.1016/j.cell.2011.03.041PubMed Abstract | CrossRef Full Text | Google Scholar
44
SfeirA.KosiyatrakulS. T.HockemeyerD.MacRaeS. L.KarlsederJ.SchildkrautC. L.et al (2009). Mammalian Telomeres Resemble Fragile Sites and Require TRF1 for Efficient Replication. Cell138, 90–103. 10.1016/j.cell.2009.06.021PubMed Abstract | CrossRef Full Text | Google Scholar
45
SharmaS.SommersJ. A.WuL.BohrV. A.HicksonI. D.BroshR. M.Jr. (2004). Stimulation of Flap Endonuclease-1 by the Bloom's Syndrome Protein. J. Biol. Chem.279, 9847–9856. 10.1074/jbc.m309898200PubMed Abstract | CrossRef Full Text | Google Scholar
46
ShastriV. M.SubramanianV.SchmidtK. H. (2021). A Novel Cell-Cycle-Regulated Interaction of the Bloom Syndrome Helicase BLM with Mcm6 Controls Replication-Linked Processes. Nucleic Acids Res.49, 8699–8713. 10.1093/nar/gkab663PubMed Abstract | CrossRef Full Text | Google Scholar
47
ShimaH.SuzukiH.SunJ.KonoK.ShiL.KinomuraA.et al (2013). Activation of the SUMO Modification System Is Required for the Accumulation of RAD51 at Sites of DNA Damage. J. Cell Sci.126, 5284–5292. 10.1242/jcs.133744PubMed Abstract | CrossRef Full Text | Google Scholar
48
ShorrocksA.-M. K.JonesS. E.TsukadaK.MorrowC. A.BelblidiaZ.ShenJ.et al (2021). The Bloom Syndrome Complex Senses RPA-Coated Single-Stranded DNA to Restart Stalled Replication Forks. Nat. Commun.12, 585. 10.1038/s41467-020-20818-5PubMed Abstract | CrossRef Full Text | Google Scholar
49
SidorovaJ. M.LiN.SchwartzD. C.FolchA.Monnat JrR. J.Jr. (2009). Microfluidic-assisted Analysis of Replicating DNA Molecules. Nat. Protoc.4, 849–861. 10.1038/nprot.2009.54PubMed Abstract | CrossRef Full Text | Google Scholar
50
SoniatM. M.MylerL. R.KuoH.-C.PaullT. T.FinkelsteinI. J. (2019). RPA Phosphorylation Inhibits DNA Resection. Mol. Cell75, 145–153. 10.1016/j.molcel.2019.05.005PubMed Abstract | CrossRef Full Text | Google Scholar
51
SpiesJ.LukasC.SomyajitK.RaskM.-B.LukasJ.NeelsenK. J. (2019). 53BP1 Nuclear Bodies Enforce Replication Timing at Under-replicated DNA to Limit Heritable DNA Damage. Nat. Cell Biol.21, 487–497. 10.1038/s41556-019-0293-6PubMed Abstract | CrossRef Full Text | Google Scholar
52
TécherH.KoundrioukoffS.AzarD.WilhelmT.CarignonS.BrisonO.et al (2013). Replication Dynamics: Biases and Robustness of DNA Fiber Analysis. J. Mol. Biol.425, 4845–4855. 10.1016/j.jmb.2013.03.040PubMed Abstract | CrossRef Full Text | Google Scholar
53
VeselaE.ChromaK.TuriZ.MistrikM. (2017). Common Chemical Inductors of Replication Stress: Focus on Cell‐Based Studies. Biomolecules7, 19. 10.3390/biom7010019PubMed Abstract | CrossRef Full Text | Google Scholar
54
WhelanD. R.RothenbergE. (2021). Super-resolution Mapping of Cellular Double-Strand Break Resection Complexes during Homologous Recombination. Proc. Natl. Acad. Sci. U.S.A.118, e2021963118. 10.1073/pnas.2021963118PubMed Abstract | CrossRef Full Text | Google Scholar
55
WuL.BachratiC. Z.OuJ.XuC.YinJ.ChangM.et al (2006). BLAP75/RMI1 Promotes the BLM-dependent Dissolution of Homologous Recombination Intermediates. Proc. Natl. Acad. Sci. U.S.A.103, 4068–4073. 10.1073/pnas.0508295103PubMed Abstract | CrossRef Full Text | Google Scholar
56
WuL.HicksonI. D. (2003). The Bloom's Syndrome Helicase Suppresses Crossing over during Homologous Recombination. Nature426, 870–874. 10.1038/nature02253PubMed Abstract | CrossRef Full Text | Google Scholar
57
XiaoZ.ChangJ.-G.HendriksI. A.SigurðssonJ. O.OlsenJ. V.VertegaalA. C. O. (2015). System-wide Analysis of SUMOylation Dynamics in Response to Replication Stress Reveals Novel Small Ubiquitin-like Modified Target Proteins and Acceptor Lysines Relevant for Genome Stability. Mol. Cell. Proteomics14, 1419–1434. 10.1074/mcp.o114.044792PubMed Abstract | CrossRef Full Text | Google Scholar
58
YankiwskiV.MarciniakR. A.GuarenteL.NeffN. F. (2000). Nuclear Structure in Normal and Bloom Syndrome Cells. Proc. Natl. Acad. Sci. U.S.A.97, 5214–5219. 10.1073/pnas.090525897PubMed Abstract | CrossRef Full Text | Google Scholar
59
ZellwegerR.DalcherD.MutrejaK.BertiM.SchmidJ. A.HerradorR.et al (2015). Rad51-mediated Replication Fork Reversal Is a Global Response to Genotoxic Treatments in Human Cells. J. Cell Biol.208, 563–579. 10.1083/jcb.201406099PubMed Abstract | CrossRef Full Text | Google Scholar
60
ZemanM. K.CimprichK. A. (2014). Causes and Consequences of Replication Stress. Nat. Cell Biol.16, 2–9. 10.1038/ncb2897PubMed Abstract | CrossRef Full Text | Google Scholar
61
ZhangR.SenguptaS.YangQ.LinkeS. P.YanaiharaN.BradsherJ.et al (2005). BLM Helicase Facilitates Mus81 Endonuclease Activity in Human Cells. Cancer Res.65, 2526–2531. 10.1158/0008-5472.can-04-2421PubMed Abstract | CrossRef Full Text | Google Scholar
62
ZhuJ.ZhuS.GuzzoC. M.EllisN. A.SungK. S.ChoiC. Y.et al (2008). Small Ubiquitin-Related Modifier (SUMO) Binding Determines Substrate Recognition and Paralog-Selective SUMO Modification. J. Biol. Chem.283, 29405–29415. 10.1074/jbc.m803632200PubMed Abstract | CrossRef Full Text | Google Scholar
63
ZimmermannM.KibeT.KabirS.de LangeT. (2014). TRF1 Negotiates TTAGGG Repeat-Associated Replication Problems by Recruiting the BLM Helicase and the TPP1/POT1 Repressor of ATR Signaling. Genes Dev.28, 2477–2491. 10.1101/gad.251611.114PubMed Abstract | CrossRef Full Text | Google Scholar
Summary
Keywords
Bloom syndrome, BLM, DNA replication, sumoylation, replication fork stalling
Citation
de Renty C, Pond KW, Yagle MK and Ellis NA (2022) BLM Sumoylation Is Required for Replication Stability and Normal Fork Velocity During DNA Replication. Front. Mol. Biosci. 9:875102. doi: 10.3389/fmolb.2022.875102
Received
13 February 2022
Accepted
09 June 2022
Published
01 July 2022
Volume
9 - 2022
Edited by
Huiming Lu, University of Texas Southwestern Medical Center, United States
Reviewed by
Alexandre Maréchal, Université de Sherbrooke, Canada
Shuai Wang, University of Texas Southwestern Medical Center, United States
Updates
Copyright
© 2022 de Renty, Pond, Yagle and Ellis.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Nathan A. Ellis, naellis@arizona.edu
† Present address: Christelle de Renty, Bioscience, Oncology R&D, AstraZeneca, Cambridge, United Kingdom
This article was submitted to Molecular Diagnostics and Therapeutics, a section of the journal Frontiers in Mlecular Biosciences
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.